In an updated policy statement, the American Society for Reproductive Medicine says transgender status should not prevent a patient from accessing fertility preservation. Further, reproductive services should be offered to all interested transgender or nonbinary individuals, barring other disqualifying factors (based on empirical evidence as opposed to bias or stereotypes).
The risk evaluation and mitigation strategy (REMS) restriction on mifepristone has been burdensome for providers and patients, researchers noted. The REMS restriction exacerbates the stigma around abortion care, which already disproportionately affects communities of color and young people.
Planned Parenthood and other reproductive health organizations have initiated COVID-19 vaccine outreach for their patients and communities. In addition to encouraging staff and patients to take the vaccine, the organizations have taken a positive COVID-19 vaccine message to minority communities and others hit hard by the pandemic.